ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection targets tough liver cancer in small early trial
Disease control Not yet recruitingThis early-phase study tests the safety and tolerability of a new drug called SZ1003 in 12 people with advanced liver cancer that has not responded to at least two prior treatments. The main goal is to check for side effects over 24 weeks, while also looking at whether the drug c…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for liver cancer patients who Can't have surgery?
Disease control Not yet recruitingThis study tests the drug lenvatinib as the first treatment for people with advanced liver cancer who cannot have surgery or other curative treatments. It includes 50 adults with a specific type of liver function (Child-Pugh B). The goal is to see if lenvatinib can slow cancer gr…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated May 13, 2026 15:58 UTC